Westat researchers publish on a wide array of topics that further our understanding of the field and focus on improving lives through research. Selected publications that communicate our findings, including books, peer-reviewed articles and technical reports, conference proceedings, and more are presented here.


Natarajan K., Prasad N., Dascomb K., Irving S.A., Yang D.-H., Gaglani M., Klein N.P., DeSilva M.B., Ong T.C., Grannis S.J., Stenehjem E., Link-Gelles R., Rowley E.A., Naleway A.L., Han J., Raiyani C., Benitez G.V., Rao S., Lewis N., Fadel W.F., Grisel N., Griggs E.P., Dunne M.M., Stockwell M.S., Mamawala M., McEvoy C., Barron M.A., Goddard K., Valvi N.R., Arndorfer J., Patel P., Mitchell P.K., Smith M., Kharbanda A.B., Fireman B., Embi P.J., Dickerson M., Davis J.M., Zerbo O., Dalton A.F., Wondimu M.H., Azziz-Baumgartner E., Bozio C.H., Reynolds S., Ferdinands J., Williams J., Schrag S.J., Verani J.R., Ball S., Thompson M.G., and Dixon B.E. (2022).

Effectiveness of homologous and heterologous COVID-19 booster doses following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) vaccine dose against COVID-19-associated emergency department and urgent care encounters and hospitalizations among adults.

Strongin R.M., Sharma E., Erythropel H.C., El-Hellani A., Kassem N.O.F., Mikheev V.B., Noël A., Peyton D.H., and Springer M.L. (2022).

Emerging ENDS products and challenges in tobacco control toxicity research.

Klein N.P., Stockwell M.S., Demarco M., Gaglani M., Kharbanda A.B., Irving S.A., Rao S., Grannis S.J., Dascomb K., Murthy K., Rowley E.A., Dalton A.F., DeSilva M.B., Dixon B.E., Natarajan K., Stenehjem E., Naleway A.L., Lewis N., Ong T.C., Patel P., Konatham D., Embi P.J., Reese S.E., Grisel N., Goddard K., Barron M.A., Dickerson M., Liao I.-C., Fadel W.F., Yang D.-H., Arndorfer J., Fireman B., Griggs E.P., Valvi N.R., Hallowell C., Zerbo O., Reynolds S., Ferdinands J., Wondimu M.H., Williams J., Bozio C.H., Link-Gelles R., Azziz-Baumgartner E., Schrag S.J., Thompson M.G., and Verani J.R. (2022).

Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA vaccination in preventing COVID-19-associated emergency department and urgent care encounters and hospitalizations among nonimmunocompromised children and adolescents aged 5–17 years — VISION Network.

Saa P., Fink R.V., Bakkour S., Jin J., Simmons G., Muench M.O., Dawar H., Di Germanio C., Hui A.J., Wright D.J., Krysztof D.E., Kleinman S.H., Cheung A., Nester T., Kessler D.A., Townsend R.L., Spencer B.R., Kamel H., Vannoy J.M., Dave H., Busch M.P., Stramer S.L., Stone M., Jackman R.P., and Norris P.J. (2022).

Frequent detection but lack of infectivity of SARS-CoV-2 RNA in presymptomatic, infected blood donor plasma.

George P., Ghose S.S., Goldman H.H., O'Brien J., Daley T.C., Dixon L.B., and Rosenblatt A. (2022).

Growth of coordinated specialty care in the United States with changes in federal funding policies: 2014–2018.

Kasza K.A., Tang Z., Xiao H., Marshall D., Stanton C., Gross A.L., Jackson K.M., Kelley D., Schroeder M.J., Vivar J.C., and Hyland A. (2022).

National longitudinal tobacco product cessation rates among US adults from the PATH Study: 2013–2019 (waves 1–5).

Anderson C.E., Martinez C.E., Ritchie L.D., Paolicelli C., Reat A., Borger C., and Whaley S.E. (2022).

Longer Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) participation duration is associated with higher diet quality at age 5 years.

Li J., Krenzke T., Ren W., Mohadjer L., Fay R., and Erciulescu A. (2022).

Program for the International Assessment of Adult Competencies (PIAAC): State-level estimation for age and education groups methodology report.

Aikin K.J., Sullivan H.W., Caporaso A., Hoverman V., Yan T., Williams D., and Crafts J. (2022).

Attention to risk information in direct-to-consumer prescription drug print ads: An eye-tracking study.

West B.A., Reed M.P., Benedick A., De Leonardis D., Huey R., and Sauber-Schatz E. (2022).

Belt fit for children in vehicle seats with and without belt-positioning boosters.

Want to work with us?
You’ll be in great company.

About Us Careers

Westat Employees.
Westat Employee.
AAA Foundation for Traffic Safety
Baltimore Metropolitan Council
Centers for Disease Control and Prevention
Centers for Medicare & Medicaid Services
Chicago Metropolitan Agency for Planning
DC Public Schools
Georgia Department of Transportation
Internal Revenue Service
Leadership Montgomery
Maryland Cancer Registry
Michigan Department of Health and Human Services
National Science Foundation
NYC Mayor’s Office for Economic Opportunity
Organization for Economic Cooperation and Development
Robert Wood Johnson Foundation
Social Security Administration
Substance Abuse and Mental Health Services Administration
Teach for America
Texas Education Agency
The Johns Hopkins University
The National Institutes of Health
The Verizon Foundation
U.S. Department of Agriculture
U.S. Department of Education
U.S. Department of Health and Human Services
U.S. Department of Justice
U.S. Department of Transportation
U.S. Department of Veterans Affairs
University of Maryland Baltimore Campus
University of Michigan
University System of Maryland
Explore Our Clients

Please wait...

Forbes 2023 America's Best Mid-Size Employers Powered by Statista Forbes 2022 The Best Employers for Women Powered by Statista

Westat is an Equal Opportunity Employer and does not discriminate on the basis of race, creed, color, religion, sex, national origin, age, veteran status, disability, marital status, sexual orientation, citizenship status, genetic information, gender identity or expression, or any other protected status under applicable law. Notices to Employees & Applicants.